
Age affects uveitis impact
A team of New Zealand researchers has shown that age appears to be a key factor influencing the underlying aetiology and clinical course of uveitis. Published in the American Journal of Ophthalmolog

A team of New Zealand researchers has shown that age appears to be a key factor influencing the underlying aetiology and clinical course of uveitis. Published in the American Journal of Ophthalmolog

Asserting a unique character and strong quest for innovation, JF Rey’s award-winning Sledge Series

A literature review comparing repeated low-level red light (RLRL) therapy with single vision spectacles (SVS) found RLRL treatment led to “considerable reductions” in both axial length (AL) and spheri

Alcon is cutting back on packaging material manufacturing and reducing waste going to NZ landfills.

Silmo Singapore, planned for 23–25 April 2025, is cancelled. The cancellation occurred in a market plagued by the rise in both travel costs and prices in Singapore, causing several major business

Angela Mitchell is partnering with New Zealand’s largest independent optometry group, Matthews Eyecare, as co-owner of Orewa Optics. Mitchell’s former business partner, long-serving dispensing optician Petra Hewitt, is stepping away from day-to-day optics to pursue adventures with her family.

The Therapeutics Products Act (TPA) 2023 has been repealed, despite being hailed by now-former health minister Dr Ayesha Verrall as the most significant change to the regulation of medicines, medical devices and natural health products in New Zealand in nearly 40 years.

Danish brand Monoqool has created its first AI-generated design, Wild Thing. Generated via text prompts, the AI design was refined through countless alterations, said the company. The technology offered lots of inspiration for how a unique pair of glasses could look, it said.

BLVNZ is pulling the plug on its joint venture with Rotary to fund and operate a Southern Vision Bus.

CDR-Life is recruiting for phase 2 clinical trials of its novel antibody fragment-based therapy for geographic atrophy (GA), following favourable phase 1 safety results.

A groundbreaking, experimental stem cell treatment for blinding cornea injuries resulted in a 92% success rate at 18 months.

Blackfin’s latest campaign introduces a collection combining innovation and style through the brand’s minimalistic creative vision and cutting-edge technologies. With new designs available in the Blackfin One, Areo Loop, Pacific and Atlantic series, the Pacific Mendocino featured here stands out for